You have no items in your shopping cart.
Cart summary
Item 1 of 1
Erythromycin Resistance Peptide MRLFV
Catalog Number: orb321046
| Catalog Number | orb321046 |
|---|---|
| Category | Small Molecules |
| Description | Erythromycin Resistance Peptide MRLFV |
| Purity | ≥95% |
| MW | 664.86 |
| Solubility (25°C) | Soluble in water. |
| CAS Number | 193763-81-4 |
| Formula | C31H52N8O6S |
| SMILES | CC(C)C[C@@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)N |
| Storage | Storage Temp: -20°C |
| Alternative names | E-peptide |
| Note | For research use only |
| Expiration Date | 12 months from date of receipt. |
- Item 1 of 1
For example, if the dosage of your experiment is 10mg/kg, the weight of each animal is 50g, and the volume of the dosing is 100μL, then the working solution concentration of your experiment is 5mg/mL. If the formula you used is 5% DMSO+ 30% PEG300+ 5% Tween 80 + 60% Saline/PBS/ddH2O, the preparation method is as follows:
Mother liquor preparation method: 5mg of drug dissolved in 100μL DMSO (mother liquor concentration is 50mg/mL). Preparation method of in vivo formulation: For 1mL of working solution preparation, take 50μL of DMSO mother liquor, add 300 μL of PEG300 to mix well and clarify, then add 50μL of Tween-80 to mix well and clarify, and finally add 600μL of Saline/PBS/ddH2O to mix well and clarify.Note:
- For Reference Only. Please choose the appropriate dissolution protocol according to your experimental animal and administration method.
- We suggest that in cell experiments, the final concentration of DMSO is not more than 0.1%, in animal experiments, for healthy mice, the final concentration of DMSO is not more than 10%; For nude or frail mice, the final concentration of DMSO is not more than 2%.
